CRISPR genome-editing technology can be used as a tool to discover RNA therapeutics for lung cancer

An international team of scientists have demonstrated for the first time that CRISPR genome-editing technology can be used as a tool to find new gene therapies for lung cancer.

Related Keywords

Hong Kong ,Italy ,China ,Bern ,Switzerland ,Ireland ,Dublin ,Spain ,Helen Roche ,Rory Johnson ,Emily Henderson ,Research Leaders ,School Of Biology ,University Of Bern ,University College Dublin ,Conway Institute ,Science Foundation Ireland ,Associate Professor Rory Johnson ,Environmental Science ,Cancer Hallmarks ,Future Research Leaders ,Associate Professor Rory ,United Statesa ,Cancer ,Gene ,Lung Cancer ,Herapeutics ,Fell ,Rispr ,Na ,Drug Discovery ,Enome ,Genomics ,Non Small Cell Lung Cancer ,Research ,Small Cell Lung Cancer ,